BSEAGM/EGM26 Sept 2026 · 26 Sept 2026, 01:43 pm
Summary of the proceedings of 37th Annual General Meeting of the shareholders held at 12.30 P.M. through video conferencing mode.
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI SummaryMgmt Change
Venmax Drugs and Pharmaceuticals Ltd held its 37th Annual General Meeting (AGM) on September 26, 2026, through video conferencing. The meeting was attended by 45 members, and the company's Managing Director, Mr. Venkata Rao Sadhanala, briefed shareholders on the business operations and financial performance for the FY 2025-2026. The company also announced its intention to merge with Hatri Pharma Private Limited, subject to necessary approvals.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Shareholder Meeting / Postal Ballot-Outcome of AGM